GO
Loading...

Zimmer Holdings Inc

More

  • Final Glance: Medical Devices companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Allergan fell $1.86 or 1.1 percent, to $170.57. Baxter International Inc. rose$. 16 or. 2 percent, to $77.00. Boston Scientific Corp. rose$. 24 or 1.8 percent, to $13.26.

  • Midday Glance: Medical Devices companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Allergan fell$. 78 or. 5 percent, to $171.65. Baxter International Inc. rose$. 20 or. 3 percent, to $77.04. Boston Scientific Corp. rose$. 09 or. 7 percent, to $13.11.

  • Early Glance: Medical Devices companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Allergan fell $1.51 or. 9 percent, to $170.92. Baxter International Inc. fell$. 13 or. 2 percent, to $76.71. Boston Scientific Corp. rose$. 02 or. 2 percent, to $13.04.

  • Zimmer 2Q profit climbs 16 percent Thursday, 24 Jul 2014 | 10:37 AM ET

    WARSAW, Ind.— Zimmer Holdings Inc. on Thursday reported a 16 percent increase in second-quarter net income, but the surgical product maker's shares slipped in trading after it also lowered the top end of its 2014 earnings forecast.

  • Final Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Allergan fell$. 71 or. 4 percent, to $170.43. Boston Scientific Corp. rose$. 30 or 2.4 percent, to $12.85. Medtronic rose$. 30 or. 5 percent, to $62.71.

  • Early Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 11:16 AM ET

    Allergan rose $1.04 or. 6 percent, to $172.18. Baxter International Inc. rose$. 55 or. 7 percent, to $76.66. Boston Scientific Corp. rose$. 23 or 1.8 percent, to $12.78.

  • Midday Glance: Medical Devices companies Friday, 18 Jul 2014 | 1:19 PM ET

    Allergan rose $1.25 or. 8 percent, to $167.07. Baxter International Inc. fell$. 25 or. 3 percent, to $76.00. Boston Scientific Corp. rose$. 18 or 1.4 percent, to $12.64.

  • Midday Glance: Medical Devices companies Wednesday, 16 Jul 2014 | 2:54 PM ET

    Allergan rose$. 59 or. 4 percent, to $164.97. Baxter International Inc. fell$. 23 or. 3 percent, to $76.53. Boston Scientific Corp. rose$. 09 or. 7 percent, to $12.94.

  • Early Glance: Medical Devices companies Wednesday, 16 Jul 2014 | 11:11 AM ET

    Allergan rose$. 09 or. 1 percent, to $164.47. Baxter International Inc. fell$. 09 or. 1 percent, to $76.67. Boston Scientific Corp. rose$. 07 or. 5 percent, to $12.92.

  • Midday Glance: Medical Devices companies Monday, 14 Jul 2014 | 1:29 PM ET

    Allergan fell$. 34 or. 2 percent, to $166.09. Baxter International Inc. rose$. 03 or percent, to $76.62. Boston Scientific Corp. fell$. 13 or. 9 percent, to $13.17.

  • Early Glance: Medical Devices companies Monday, 14 Jul 2014 | 10:47 AM ET

    Allergan fell$. 82 or. 5 percent, to $165.61. Baxter International Inc. rose$. 20 or. 3 percent, to $76.79. Boston Scientific Corp. fell$. 10 or. 8 percent, to $13.19.

  • FACTBOX-M&A frenzy transforming global pharma Monday, 14 Jul 2014 | 9:27 AM ET

    July 14- Several multi-billion dollar deals and bids have made 2014 a busy year for healthcare acquisitions, despite Pfizer pulling its $118 billion offer for AstraZeneca.

  • June 16- Medtronic Inc's $43 billion deal for Dublin- based Covidien Plc should accelerate already intense efforts by medical device rivals to seek merger partners, industry analysts and bankers said on Monday.

  • June 14- U.S. medical device maker Medtronic Inc is in advanced talks to buy rival Covidien Plc in a deal valued at $45 billion to $50 billion, people familiar with the matter said on Saturday.

  • FACTBOX-M&A frenzy transforming global pharma Tuesday, 6 May 2014 | 2:00 PM ET

    MAY May 6- Merck& Co Inc agrees to sell its consumer care business to Germany's Bayer AG for $14.2 billion. May 2- Pfizer Inc raises its offer for AstraZeneca Plc to 63 billion pounds, but the British company promptly rejects the proposal, which would create the world's biggest pharmaceuticals company.

  • FACTBOX-M&A frenzy in healthcare sector Tuesday, 29 Apr 2014 | 2:25 PM ET

    **U.S. drugmaker Pfizer said on April 28 that it had offered to buy Britain's AstraZeneca Plc in January for about $98.9 billion, or nearly 47 pounds per share.

  • UPDATE 1-Meda board rejects new Mylan offer Monday, 28 Apr 2014 | 2:50 AM ET

    STOCKHOLM, April 28- Swedish drugmaker Meda has rejected an improved takeover offer from U.S. generics firm Mylan, saying it was confident in its future as an independent company and its biggest shareholder did not support the bid.

  • *Mylan offering 145 SEK/ share for Sweden's Meda. NEW YORK/ STOCKHOLM, April 25- U.S. generic drugmaker Mylan has made a new and improved bid for Meda valuing its Swedish rival at around $9 billion including debt, a person familiar with the matter said on Friday.

  • LONDON, April 25- The value of worldwide mergers and acquisitions announced so far this year has topped $1 trillion, only the third time deal values have surpassed this mark since records began in 1980, weekly Thomson Reuters data showed on Friday.

  • *Apple rallies a day after announcing 7- for-1 stock split. *Caterpillar gains after results; Verizon, 3 M fall. NEW YORK, April 24- The Nasdaq rose modestly in a choppy session on Thursday, lifted by a rally in Apple shares a day after the iPad maker's strong results, though tensions in Ukraine held the broader market in check.